Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (97)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Burkhart, C.
Right arrow Articles by Wraith, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burkhart, C.
Right arrow Articles by Wraith, D. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 10, 1625-1634, October 1999
© 1999 Japanese Society for Immunology

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10

Christoph Burkhart, George Y. Liu1, Stephen M. Anderton, Barbara Metzler and David C. Wraith

Department of Pathology and Microbiology, University of Bristol, Bristol BS8 1TD, UK

Correspondence to: D. C. Wraith

Experimental autoimmune encephalomyelitis (EAE) is a CD4+ T cell-mediated, inflammatory disease with similarities to multiple sclerosis in humans. Intranasal (i.n.) administration of a myelin basic protein (MBP)-derived peptide can protect susceptible mice from EAE. The mechanisms underlying this phenomenon, however, remain unclear. To analyze the phenotypic and functional changes taking place during the induction of tolerance by peptide inhalation, we have studied the fate of CD4+ T cells after i.n. peptide application using transgenic mice expressing a TCR specific for the N-terminal peptide (Ac1–9) of MBP. Peripheral T cell death was variably observed in TCR transgenic mice after a single i.n. administration of antigenic peptide but was transient and incomplete. Transgenic spleen cells and cervical lymph node cells responded with a cytokine burst to peptide inhalation and hyperproliferation when re-stimulated in vitro. Transfer experiments demonstrated that the duration of peptide administration required to induce tolerance depended on the precursor frequency of T cells in recipient animals. The stringency of i.n. peptide treatment was increased so as to test the efficacy of tolerance induction both in vitro and in vivo in the presence of high precursor frequencies of antigen-specific T cells. Multiple i.n. doses of peptide completely protected TCR transgenic mice from EAE induced with myelin. Such repeated peptide administration resulted in down-regulation of the capacity of antigen-specific CD4+ T cells to proliferate or to produce IL-2, IFN-{gamma} and IL-4 but increased the production of IL-10. The role of IL-10 in suppression of EAE in vivo was demonstrated by neutralization of IL-10. This completely restored susceptibility to EAE in mice previously protected by i.n. peptide. Considering the immunosuppressive properties of IL-10, T cells which are resistant to apoptosis might act as regulatory cells and mediate bystander suppression.

Keywords: anergy, apoptosis, immune deviation, inhalation tolerance

1 Present address: UCSD, School of Medicine, La Jolla, CA 92093-060, USA

Transmitting editor: A. Cooke


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M. Stojakovic, Z. Tatari-Calderone, C. Maric, A. Hoang, and S. Vukmanovic
Paradoxical arrest in lupus activity in BXSB mice with highly autoreactive T cells
Lupus, February 1, 2010; 19(2): 182 - 191.
[Abstract] [PDF]


Home page
JEMHome page
L. Gabrysova, K. S. Nicolson, H. B. Streeter, J. Verhagen, C. A. Sabatos-Peyton, D. J. Morgan, and D. C. Wraith
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells
J. Exp. Med., August 3, 2009; 206(8): 1755 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Zhao, S. Yu, D. C. Fitzgerald, M. Elbehi, B. Ciric, A. M. Rostami, and G.-X. Zhang
IL-12R{beta}2 Promotes the Development of CD4+CD25+ Regulatory T Cells
J. Immunol., September 15, 2008; 181(6): 3870 - 3876.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. S. Nicolson, E. J. O'Neill, A. Sundstedt, H. B. Streeter, S. Minaee, and D. C. Wraith
Antigen-Induced IL-10+ Regulatory T Cells Are Independent of CD25+ Regulatory Cells for Their Growth, Differentiation, and Function
J. Immunol., May 1, 2006; 176(9): 5329 - 5337.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Kinjyo, H. Inoue, S. Hamano, S. Fukuyama, T. Yoshimura, K. Koga, H. Takaki, K. Himeno, G. Takaesu, T. Kobayashi, et al.
Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-{beta}1
J. Exp. Med., April 17, 2006; 203(4): 1021 - 1031.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, D. Calida, Z. Zhao, B. Gran, M. Kamoun, and A. Rostami
Loss of the Surface Antigen 3G11 Characterizes a Distinct Population of Anergic/Regulatory T Cells in Experimental Autoimmune Encephalomyelitis
J. Immunol., March 15, 2006; 176(6): 3366 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Murano, X. Xiong, N. Murano, J. L. Salzer, J. J. Lafaille, and V. K. Tsiagbe
Latent TGF-{beta}1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis
J. Leukoc. Biol., January 1, 2006; 79(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, B. Gran, and A. Rostami
Glucosamine Abrogates the Acute Phase of Experimental Autoimmune Encephalomyelitis by Induction of Th2 Response
J. Immunol., December 1, 2005; 175(11): 7202 - 7208.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Hall, L. S. Cairns, D. M. Altmann, R. N. Barker, and S. J. Urbaniak
Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice
Blood, March 1, 2005; 105(5): 2175 - 2179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Taylor, K. McConnachie, C. Calder, R. Dawson, A. Dick, J. D. Sedgwick, and J. Liversidge
Enhanced Tolerance to Autoimmune Uveitis in CD200-Deficient Mice Correlates with a Pronounced Th2 Switch in Response to Antigen Challenge
J. Immunol., January 1, 2005; 174(1): 143 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. O. Anderson, A. Sundstedt, Z. Yazici, S. Minaee, R. Woolf, K. Nicolson, N. Whitley, L. Li, S. Li, D. C. Wraith, et al.
IL-2 Overcomes the Unresponsiveness but Fails to Reverse the Regulatory Function of Antigen-Induced T Regulatory Cells
J. Immunol., January 1, 2005; 174(1): 310 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. L. Vieira, J. R. Christensen, S. Minaee, E. J. O'Neill, F. J. Barrat, A. Boonstra, T. Barthlott, B. Stockinger, D. C. Wraith, and A. O'Garra
IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells
J. Immunol., May 15, 2004; 172(10): 5986 - 5993.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-G. Chai, E. James, H. Dewchand, E. Simpson, and D. Scott
Transplantation tolerance induced by intranasal administration of HY peptides
Blood, May 15, 2004; 103(10): 3951 - 3959.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-R. Shen, A.-R. Youssef, A. Devine, L. Bowie, A. M. Hall, D. C. Wraith, C. J. Elson, and R. N. Barker
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
Blood, November 15, 2003; 102(10): 3800 - 3806.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sundstedt, E. J. O'Neill, K. S. Nicolson, and D. C. Wraith
Role for IL-10 in Suppression Mediated by Peptide-Induced Regulatory T Cells In Vivo
J. Immunol., February 1, 2003; 170(3): 1240 - 1248.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Hall, F. J. Ward, M. A. Vickers, L.-M. Stott, S. J. Urbaniak, and R. N. Barker
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen
Blood, December 15, 2002; 100(13): 4529 - 4536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, H. Xu, M. Kishi, D. Calida, and A. Rostami
The Role of IL-12 in the Induction of Intravenous Tolerance in Experimental Autoimmune Encephalomyelitis
J. Immunol., March 1, 2002; 168(5): 2501 - 2507.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. G. Jarnicki, T. Tsuji, and W. R. Thomas
Inhibition of mucosal and systemic Th2-type immune responses by intranasal peptides containing a dominant T cell epitope of the allergen Der p 1
Int. Immunol., October 1, 2001; 13(10): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
A. D Dick, V. Sharma, and J. Liversidge
Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy
Br J Ophthalmol, August 1, 2001; 85(8): 1001 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
H.-R. Jiang, N. Taylor, L. Duncan, A. D Dick, and J. V Forrester
Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction
Br J Ophthalmol, June 1, 2001; 85(6): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sebastiani, P. Allavena, C. Albanesi, F. Nasorri, G. Bianchi, C. Traidl, S. Sozzani, G. Girolomoni, and A. Cavani
Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity
J. Immunol., January 15, 2001; 166(2): 996 - 1002.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. M. Anderton, C. G. Radu, P. A. Lowrey, E. S. Ward, and D. C. Wraith
Negative Selection during the Peripheral Immune Response to Antigen
J. Exp. Med., January 1, 2001; 193(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. F. HOYNE, K. TAN, M. CORSIN-JIMENEZ, K. WAHL, M. STEWART, S. E. M. HOWIE, and J. R. LAMB
Immunological Tolerance to Inhaled Antigen
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S169 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. ASSEMAN, S. FOWLER, and F. POWRIE
Control of Experimental Inflammatory Bowel Disease by Regulatory T cells
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S185 - 189.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.